Other Content - BioPharm International

ADVERTISEMENT

Other Content

Agilent - Affinity Removal High Abundant Proteins in Human Plasma

December 11, 2013

Agilent - Affinity Removal High Abundant Proteins in Human Plasma

Wockhardt Receives FDA Warning Letter

December 6, 2013

FDA cites cGMP violations and data-integrity issues and raises concerns over the company's ability to implement a robust and sustainable quality system.

The Impact of Biosimilars on the Innovator Market

December 4, 2013

Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing

Tosoh - Monoclonal Antibody Purification with a High Capacity Protein A Resin

November 26, 2013

Tosoh - Monoclonal Antibody Purification with a High Capacity Protein A Resin

Agilent - N-Terminal Site-Specific PEGylation and Analytical-Scale Purification of PEG Lysozyme

November 22, 2013

Agilent - N-Terminal Site-Specific PEGylation and Analytical-Scale Purification of PEG Lysozyme

BioPharm International Author Guidelines for Supplements for 2014

November 22, 2013

BioPharm International Author Guidelines for Supplements for 2014

BioPharm International Author Guidelines for Peer-Review Papers - 2014

November 22, 2013

BioPharm International Author Guidelines for Peer-Review Papers - 2014

ProteinSimple - MFI for Particle Characterization of Biopharmaceuticals Today

November 22, 2013

ProteinSimple - MFI for Particle Characterization of Biopharmaceuticals Today

BioPharm International Author Guidelines for Supplements

November 20, 2013

BioPharm International Author Guidelines for Supplements

ADVERTISEMENT

ADVERTISEMENT

Click here